Marathon Trading Investment Management’s Gilead Sciences GILD Stock Holding History

Marathon Trading Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,000	Closed	-$279K	–	337
2021 Q3	$279K	Buy	+4,000	New	+$281K	0.02%	271
2021 Q1	–	Sell	-10,500	Closed	-$612K	–	434
2020 Q4	$612K	Sell	10,500 -34,500	-77%	-$2.08M	0.03%	205
2020 Q3	$2.84M	Buy	+45,000	New	+$3.12M	0.22%	72
2017 Q3	–	Sell	-19,300	Closed	-$1.37M	–	150
2017 Q2	$1.37M	Buy	+19,300	New	+$1.28M	0.25%	61
2015 Q3	–	Sell	-25,000	Closed	-$2.93M	–	357
2015 Q2	$2.93M	Sell	25,000 -25,000	-50%	-$2.73M	0.12%	124
2015 Q1	$4.91M	Buy	50,000 +44,500	+809%	+$4.52M	0.25%	76
2014 Q4	$519K	Sell	5,500 -2,700	-33%	-$279K	0.01%	411
2014 Q3	$873K	Sell	8,200 -14,000	-63%	-$1.37M	0.02%	165
2014 Q2	$1.84M	Buy	22,200 +7,700	+53%	+$599K	0.06%	121
2014 Q1	$1.03M	Buy	+14,500	New	+$1.14M	0.04%	103

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marathon Trading Investment Management's GILD Position: Q4 2020 in Review

Marathon Trading Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 9,600 shares — an estimated $579K sold.

Marathon Trading Investment Management first reported a position in GILD in Q1 2014 and held it in 10 quarters. The position peaked at $1.99M in Q2 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

Marathon Trading Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
Marathon Trading Investment Management sold 9,600 Gilead Sciences shares in Q4 2020, an estimated $579K.
Marathon Trading Investment Management first reported a position in Gilead Sciences in Q1 2014 and held it in 10 quarters.
Marathon Trading Investment Management's Gilead Sciences position peaked at $1.99M in Q2 2015.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Marathon Trading Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.